| 1 |
Ryanto GRT, Musthafa A, Hara T, Emoto N. Inactivating the Uninhibited: The Tale of Activins and Inhibins in Pulmonary Arterial Hypertension. Int J Mol Sci 2023;24. [PMID: 36834742 DOI: 10.3390/ijms24043332] [Reference Citation Analysis]
|
| 2 |
Chiang J, Lin L, Wu C, Hwang J, Yang W, Wu Y. Serum myostatin level is associated with myocardial scar burden by SPECT myocardial perfusion imaging. Clinica Chimica Acta 2022;537:9-15. [DOI: 10.1016/j.cca.2022.09.024] [Reference Citation Analysis]
|
| 3 |
Balsano R, Kruize Z, Lunardi M, Comandatore A, Barone M, Cavazzoni A, Re Cecconi AD, Morelli L, Wilmink H, Tiseo M, Garajovà I, van Zuylen L, Giovannetti E, Piccirillo R. Transforming Growth Factor-Beta Signaling in Cancer-Induced Cachexia: From Molecular Pathways to the Clinics. Cells 2022;11:2671. [DOI: 10.3390/cells11172671] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 4 |
Queiroz AL, Dantas E, Ramsamooj S, Murthy A, Ahmed M, Zunica ERM, Liang RJ, Murphy J, Holman CD, Bare CJ, Ghahramani G, Wu Z, Cohen DE, Kirwan JP, Cantley LC, Axelrod CL, Goncalves MD. Blocking ActRIIB and restoring appetite reverses cachexia and improves survival in mice with lung cancer. Nat Commun 2022;13:4633. [PMID: 35941104 DOI: 10.1038/s41467-022-32135-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 5 |
Baig MH, Ahmad K, Moon JS, Park S, Ho Lim J, Chun HJ, Qadri AF, Hwang YC, Jan AT, Ahmad SS, Ali S, Shaikh S, Lee EJ, Choi I. Myostatin and its Regulation: A Comprehensive Review of Myostatin Inhibiting Strategies. Front Physiol 2022;13:876078. [DOI: 10.3389/fphys.2022.876078] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 6 |
Pinjusic K, Dubey OA, Egorova O, Nassiri S, Meylan E, Faget J, Constam DB. Activin-A impairs CD8 T cell-mediated immunity and immune checkpoint therapy response in melanoma. J Immunother Cancer 2022;10:e004533. [PMID: 35580932 DOI: 10.1136/jitc-2022-004533] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 7 |
Ramya Devi KT, Karthick D, Saravanaraj KS, Jaganathan MK, Ghorai S, Hemdev SP. The roles of microRNA in pancreatic cancer progression. Cancer Invest 2022;:1-26. [PMID: 35333689 DOI: 10.1080/07357907.2022.2057526] [Reference Citation Analysis]
|
| 8 |
Saha S, Singh PK, Roy P, Kakar SS. Cardiac Cachexia: Unaddressed Aspect in Cancer Patients. Cells 2022;11:990. [PMID: 35326441 DOI: 10.3390/cells11060990] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 9 |
Talbert EE, Guttridge DC. Emerging signaling mediators in the anorexia–cachexia syndrome of cancer. Trends in Cancer 2022. [DOI: 10.1016/j.trecan.2022.01.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 10 |
Zimmers TA. Tumours block protective muscle and nerve signals to cause cachexia. Nature 2021;598:37-8. [PMID: 34548663 DOI: 10.1038/d41586-021-02492-9] [Reference Citation Analysis]
|
| 11 |
Campelj DG, Goodman CA, Rybalka E. Chemotherapy-Induced Myopathy: The Dark Side of the Cachexia Sphere. Cancers (Basel) 2021;13:3615. [PMID: 34298829 DOI: 10.3390/cancers13143615] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 12 |
Li Y, Jin H, Chen Y, Huang T, Mi Y, Zou Z. Cancer cachexia: molecular mechanism and pharmacological management. Biochem J 2021;478:1663-88. [PMID: 33970218 DOI: 10.1042/BCJ20201009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
|
